Alphamab Oncology (HKSE:09966) PEG Ratio: N/A (As of Aug. 20, 2026)

Alphamab Oncology  (HKSE:09966) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.

Alphamab Oncology PEG Ratio Related Terms

The historical data trend for Alphamab Oncology's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alphamab Oncology PEG Ratio Chart

Alphamab Oncology Annual Data
	Trend	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24	Dec25
PEG Ratio		Get a 7-Day Free Trial				0.00	0.00	0.00	0.00	0.00

Alphamab Oncology Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
PEG Ratio	Get a 7-Day Free Trial												0.00	0.00	0.00	0.00	0.00

HKSE:09966 vs VRTX, REGN, RVMD: PEG Ratio Comparison

For the Biotechnology subindustry, Alphamab Oncology's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alphamab Oncology PEG Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alphamab Oncology's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Alphamab Oncology's PEG Ratio falls into.

Alphamab Oncology PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Alphamab Oncology's PEG Ratio for today is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.

Alphamab Oncology Business Description